No abstract available.
C-Reactive Protein* ; Pregnancy*

No abstract available.
C-Reactive Protein* ; Tocolysis*

No abstract available.
C-Reactive Protein*

BACKGROUND: Several immunological abnormalities, such as decreased T-cell interleukin-2 production and abnormal cellular and humoral reactivity to neurons, had been associated with patients who have schizophrenia. Several researches have been conducted to study the correlation of elevated inflammatory markers with the symptomatology of schizophrenia. OBJECTIVES: The aim of this study is to determine the levels of C-reactive protein, which is a general marker for infection and inflammation, in patients with Schizophrenia in acute exacerbation and compare these to the levels of C-reactive protein in patients with Schizophrenia in remission. METHODS: A cross-sectional study was carried out on in-patients at the Veterans Memorial Medical Center Department of Psychiatry. Serum levels of C-reactive protein in adult patients were determined during an acute exacerbation of Schizophrenia. These were compared to Creactive protein levels of patients with Schizophrenia in remission. PASW Statistics 18 (SPSS) was used for data management, tabulation and analysis. RESULTS: Cases of eighty-six (86) patients, seen by the principal investigator during OPD consults were reviewed, 43 of which had Schizophrenia in Acute Exacerbation and also 43 of patients were in Remission. The mean CRP level of patients in acute exacerbation was 7.05 mg/L (SD=0.23), which was higher than the mean CRP level of patients in remission at 5.30 mg/L (SD=0.30). CONCLUSION This study demonstrated that a stronger association exists between an acute exacerbation of Schizophrenia and elevated C-Reactive protein, in the absence of another systemic inflammatory disease when compared to the association between levels of Creactive protein in patients with Schizophrenia, in remission. This finding could pave the way for initiation of studies examining whether adjunct treatment of anti-inflammatory drugs with anti-psychotics will improve disease outcome.
C-Reactive Protein ; Schizophrenia

No abstract available.
C-Reactive Protein ; Cardiovascular Diseases

No abstract available.
C-Reactive Protein* ; Neutrophils* ; Ureter*

No abstract available.
C-Reactive Protein* ; Neutrophils* ; Ureter*

C-reactive protein (CRP) is an acute-phase protein in normal serum which increases significantly with tissue necrosis due to inflammation. To discover the level of protein C-reactive as a screening parameter for inflammatory diseases and rheumatic diseases, the CRP latex quick test was performed in 172 patients who were treated at the Rheumatology Dep. Bach mai Hospital from 2/1998 to 2/1999. The result shown that 100% patients with rheumatic fever had CRP positively, as well as 85,4% patients with rheumatics arthritis, 75% patients with connective disorders, 70% patients with ankylosing spondilitis and 20% patients with osteoarthritis. CRP is a valuable screening test in acute rheumatic arthritis as a routine diagnostic test, especially with the group of patients with rheumatic fever. However, this examination has an adequate sensitivity and specificity as well as erythrocyte sedimentation rate (ESR).
Rheumatic Diseases ; C-Reactive Protein

Some protein, at acute phase were usually used to diagnose and to monitor the status of inflammation in infection diseases. In healthy person, CRP exists only in the form of patch, but CRP is as an sensitive indicator of a reaction of systemic inflammation, in turn, inflammation had a key role in physiopathology of arteriosclerosis. Person with high content of CRP will have a 4.5 fold risk of heart attack in comparing with healthy one. Moreover it has diverse manifestations in other severe diseases such as blood sugar disorders, dental gingival diseases, smoking, overweight and obese
Inflammation ; C-Reactive Protein ; diagnosis ;

No abstract available.
Bacterial Infections* ; C-Reactive Protein*